Relmada Therapeutics, Inc. (RLMD)
7.48
+0.48
(+6.86%)
USD |
NASDAQ |
Apr 17, 16:00
7.47
-0.01
(-0.13%)
After-Hours: 20:00
Relmada Therapeutics Free Cash Flow : -45.79M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Theravance Biopharma, Inc. | 238.50M |
| Avalo Therapeutics, Inc. | -51.46M |
| AN2 Therapeutics, Inc. | -29.83M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.60M |
| Cash from Investing (Quarterly) | -76.93M |
| Cash from Financing (Quarterly) | 93.64M |
| Free Cash Flow Per Share (Quarterly) | -0.2138 |
| Free Cash Flow to Equity (Quarterly) | -14.60M |
| Free Cash Flow to Firm (Quarterly) | -14.60M |
| Free Cash Flow Yield | -14.84% |